Ralinepag

DB12462InvestigationalSmall molecule

Ralinepag has been used in trials studying the treatment of Pulmonary Arterial Hypertension.

Chemical structure of Ralinepag
Mechanism
Curator reviewed
Formula / weight
C23H26ClNO5 · 431.91 g/mol (avg)
Also known as
2-{[(1r,4r)-4-(((4-chlorophenyl)(phenyl)carbamoyloxy)methyl)cyclohexy]methoxy} acetic acid
Code names
APD-811

Resolves to

Compound
UNIICQY12ZJN6ECAS1187856-49-0ChEMBLCHEMBL3301604PubChem44219292
Structure
InChIKeyNPDKXVKJRHPDQT-IYARVYRRSA-NSMILESOC(=O)COC[C@H]1CC[C@H](COC(=O)N(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)CC1
Targets
P43119PTGIR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ralinepag, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In